Table 1.
Variables | Training Cohort (n=60) | Test Cohort (n=120) | Validation Cohort (n=150) | ||||
---|---|---|---|---|---|---|---|
| |||||||
Controls | |||||||
| |||||||
Age | Mean ± SD |
51 ± 11 | 40 ± 18 | 53 ± 20 | |||
Median (range) | 55 (27 – 63) | 29 (21 – 73) | 64 (22 – 74) | ||||
| |||||||
Gender | Male |
6 | 12 | 9 | |||
Female | 4 | 8 | 16 | ||||
| |||||||
Race | Caucasian |
10 | 16 | 23 | |||
African American |
0 | 4 | 2 | ||||
Asian | 0 | 0 | 0 | ||||
| |||||||
Colorectal Cancer | |||||||
| |||||||
Age | Mean ± SD |
55 ± 8 | 63 ± 8 | 59 ± 11 | |||
Median (range) | 55 (44 – 67) | 62 (47 – 76) | 59 (26 – 77) | ||||
| |||||||
Gender | Male |
5 | 10 | 12 | |||
Female | 5 | 10 | 13 | ||||
| |||||||
Race | Caucasian |
10 | 20 | 24 | |||
African American |
0 | 0 | 1 | ||||
Asian | 0 | 0 | 0 | ||||
| |||||||
Colorectal Adenoma | |||||||
| |||||||
Age | Mean ± SD |
64 ± 8 | 59 ± 12 | 63 ± 14 | |||
Median (range) | 63 (51 – 77) | 59 (38 – 79) | 64 (42 – 89) | ||||
| |||||||
Gender | Male |
5 | 6 | 8 | |||
Female | 5 | 14 | 17 | ||||
| |||||||
Race | Caucasian |
10 | 14 | 19 | |||
African American |
0 | 4 | 5 | ||||
Asian | 0 | 2 | 1 | ||||
| |||||||
Breast Cancer | |||||||
| |||||||
Age | Mean ± SD |
60 ± 10 | 53 ± 13 | 57 ± 9 | |||
Median (range) | 59 (48 – 79) | 53 (29 – 79) | 56 (39 – 77) | ||||
| |||||||
Gender | Male |
0 | 0 | 0 | |||
Female | 10 | 20 | 25 | ||||
| |||||||
Race | Caucasian |
10 | 18 | 24 | |||
African American |
0 | 2 | 1 | ||||
Asian | 0 | 0 | 0 | ||||
| |||||||
Pancreatic Cancer | |||||||
| |||||||
Age | Mean ± SD |
59 ± 6 | 65 ± 9 | 67 ± 9 | |||
Median (range) | 60 (49 – 69) | 62 (49 – 86) | 67 (51 – 86) | ||||
| |||||||
Gender | Male |
5 | 8 | 11 | |||
Female | 5 | 12 | 14 | ||||
| |||||||
Race | Caucasian |
10 | 20 | 23 | |||
African American |
0 | 0 | 2 | ||||
Asian | 0 | 0 | 0 | ||||
| |||||||
Lung Cancer | |||||||
| |||||||
Age | Mean ± SD |
58 ± 7 | 62 ± 10 | 58 ± 11 | |||
Median (range) | 60 (44 – 66) | 62 (44 – 81) | 56 (36 – 79) | ||||
| |||||||
Gender | Male |
5 | 11 | 11 | |||
Female | 5 | 9 | 14 | ||||
| |||||||
Race | Caucasian |
8 | 17 | 23 | |||
African American |
2 | 3 | 2 | ||||
Asian | 0 | 0 | 0 | ||||
| |||||||
American Joint Committee on Cancer Stage |
Study Subjects
|
||||||
Colorectal Cancer (n=55) | Breast Cancer (n=55) | Pancreatic Cancer (n=55) | Lung Cancer (n=55) | Colorectal Advanced Adenoma (n=55) | Controls (n=55) | ||
| |||||||
0 | 4 | 4 | 2 | 4 | Not applicable >0.6cm tubulovillous or villous | Not applicable | |
| |||||||
I | 9 | 22 | 5 | 19 | |||
| |||||||
II | 22 | 16 | 31 | 14 | |||
| |||||||
III | 5 | 9 | 7 | 13 | |||
| |||||||
IV | 12 | 2 | 6 | 1 | |||
| |||||||
Not available | 3 | 2 | 4 | 4 |